Showing results (11-20 of 189) with videos related to
Sort By:
Pageof 19
The American Journal of Medicine|June 30, 1986
Have the new beta-lactams rendered the aminoglycosides obsolete for the treatment of serious nosocomial infections?R C MoelleringThe American Journal of Medicine|July 31, 1998
The specter of glycopeptide resistance: current trends and future considerationsR C MoelleringScandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Interaction between antimicrobial consumption and selection of resistant bacterial strainsR C MoelleringThe Journal of Antimicrobial Chemotherapy|October 8, 1999
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infectionsR C MoelleringClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 1998
Antibiotic resistance: lessons for the futureR C MoelleringReviews of Infectious Diseases|July 1, 1983
Therapeutic potential of rifampin in enterococcal infectionsR C Moellering, C WennerstenAntimicrobial Agents and Chemotherapy|August 1, 1981
Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillinJ I Ward, R C MoelleringAntimicrobial Agents and Chemotherapy|May 1, 1975
Studies of cephalothin: aminoglycoside synergism against enterococciA J Weinstein, R C MoelleringAntimicrobial Agents and Chemotherapy|January 1, 1983
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981B F Farber, R C MoelleringAnnals of Internal Medicine|November 1, 1982
Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillinsG M Eliopoulos, R C MoelleringPageof 19